Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like?
The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like?
The House of Representatives narrowly passed a budget...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
Just when you thought the dust had settled from the Chevron decision, the Supreme Court is gearing up to hear arguments in Federal Communications Commission v Consumers' Research next month, potentially reviving the long-dormant nondelegation...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
On inauguration day, President Trump issued an executive order rescinding several Biden-era health care initiatives, including 3 experimental drug pricing models developed by the Center for Medicare and Medicaid Innovation (CMMI). Oh boy did...
The Plot Thickens in Drug Pricing Drama
Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
The Plot Thickens in Drug Pricing Drama
Just when you thought the drug pricing debate couldn't get more interesting, Robert F. Kennedy Jr adds an unexpected twist. During closed-door Senate meetings, President Trump’s US Department of...
Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...
Last week brought 2 major developments in health care policy: President Trump's inauguration and the Centers for Medicare and Medicaid Services’ (CMS) announcement of 15 additional drugs selected for Medicare price negotiations. While these...
The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...
The 119th Congress faces immediate health care deadlines amid significant leadership transitions. While much attention focuses on high-profile nominations like Dr Oz for Centers for Medicare and Medicaid Services (CMS) Administrator and...
New research suggests people with hemophilia had a consistently higher prevalence of hemorrhagic stroke, intracranial hemorrhage, and gastrointestinal bleeding compared to those without the disorder.
New research suggests people with hemophilia had a consistently higher prevalence of hemorrhagic stroke, intracranial hemorrhage, and gastrointestinal bleeding compared to those without the disorder.
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Despite the prevalence of obesity and metabolic conditions increasing in patients with inflammatory bowel disease over the past decade, the prescription rate for anti-obesity medications has only slightly increased, researchers said.
Researchers studied the impact of mepolizumab on gene co-expression in airway eosinophils, mast cells, and epithelium among pediatric patients with asthma.
Researchers studied the impact of mepolizumab on gene co-expression in airway eosinophils, mast cells, and epithelium among pediatric patients with asthma.
Saleem Alinur, Sharon Lee, and Lorene Perona from ScionHealth's Kindred Hospitals discuss the importance of helping medically complex patients discharge to home after a hospital stay, and how Kindred is achieving this goal.
Saleem Alinur, Sharon Lee, and Lorene Perona from ScionHealth's Kindred Hospitals discuss the importance of helping medically complex patients discharge to home after a hospital stay, and how Kindred is achieving this goal.
New research indicates that adding an anti-CD20 monoclonal antibody to a BTK inhibitor in patients with untreated or relapsed/refractory CLL could provide significantly superior efficacy with an equally safe profile.
New research indicates that adding an anti-CD20 monoclonal antibody to a BTK inhibitor in patients with untreated or relapsed/refractory CLL could provide significantly superior efficacy with an equally safe profile.